½ÃÀ庸°í¼­
»óǰÄÚµå
1608069

¼¼°èÀÇ À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå : ÀûÀÀ Áúȯ, ÃÖÁ¾ »ç¿ëÀÚ, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Implantable Loop Recorders Market by Disease Indication (Amyloidosis, Congenital Heart Disease, Obstructive Sleep Apnea), End-user (Cardiac Centers, Hospitals), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 199 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀåÀº 2023³â¿¡ 15¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 17¾ï 6,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 11.49%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 34¾ï ´Þ·¯·Î ¿¹ÃøµË´Ï´Ù.

À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ(ILR)´Â Àå±â°£¿¡ °ÉÃÄ ºÎÁ¤¸ÆÀ» °ËÃâÇÏ´Â ¿¬¼Ó ½ÉÀå ¸ð´ÏÅ͸µ¿¡ »ç¿ëµÇ´Â ¼ÒÇü ÇÇÇÏ ¹èÄ¡ ÀåÄ¡ÀÔ´Ï´Ù. ILRÀº ÀüÅëÀûÀÎ ½ÉÀüµµ¿¡¼­ ÆÄ¾ÇÇϱ⠾î·Á¿î ÀϽÃÀûÀÎ Áõ»ó¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÏ¿© ºÎÁ¤¸ÆÀÌ ÀǽɵÇÁö¸¸ Áø´ÜµÇÁö ¾ÊÀº ȯÀÚ¿¡ ´ëÇÑ °ß°íÇÑ ÇØ°áÃ¥À» Á¦°øÇÕ´Ï´Ù. ILRÀÇ ÁÖ¿ä Çʿ伺Àº ´Ü±âÀûÀÎ Á¢±Ù¹ýÀÇ ÇѰ踦 ´Ù·ç´Â Àå±â Áø´Ü ´É·Â¿¡ ÀÖÀ¸¸ç, ¿øÀÎ ºÒ¸íÀÇ ½Ç½Å, ºÎÁ¤¸ÆÀ¸·Î ÀÎÇÑ ³úÁ¹Áß ¹× ¿øÀÎ ºÒ¸íÀÇ ³úÁ¹Áß Áø´Ü¿¡ ÇʼöÀûÀÔ´Ï´Ù. È®´ëÇÏ´Â ¿ëµµ·Î´Â ½É¹æ¼¼µ¿ Ä¡·á ÈÄÀÇ ¸ð´ÏÅ͸µÀ̳ª ³úÁ¹Áß À§ÇèÀÌ ³ôÀº ȯÀÚÀÇ °ü¸® µîÀÌ ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃÖÁ¾ ¿ëµµ ºÐ¾ß´Â º´¿ø, ½ÉÀå Ä¡·á ¼¾ÅÍ, Áø´Ü Ŭ¸®´Ð µîÀÔ´Ï´Ù. ILR ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀåºñÀÇ Á¤È®¼º°ú µ¥ÀÌÅÍ È¹µæÀ» Çâ»ó½ÃŰ´Â ±â¼úÀÇ Áøº¸, ºÎÁ¤¸ÆÀ» µ¿¹ÝÇÑ ³ëÀÎ Àα¸ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ILRÀ» ÷´Ü ¿ø°Ý ÀÇ·á ¼Ö·ç¼Ç ¹× AI ÁÖµµ µ¥ÀÌÅÍ ºÐ¼®°ú ÅëÇÕÇÏ¿© ½Ç½Ã°£À¸·Î ȯÀÚ ¸ð´ÏÅ͸µ ¹× ¿¹Ãø Áø´ÜÀ» ÃËÁøÇÒ ¼ö ÀÖ´Â ±âȸ°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀåÀº Àåºñ ¹× Ä¡·á ºñ¿ë, Á¦ÇÑµÈ ÀÎÁöµµ, °¨¿° ¹× Àåºñ °ü·Ã ¹®Á¦¿Í °°Àº ÀáÀçÀû ÇÕº´Áõ°ú °°Àº °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦»óÀÇ Àå¾Ö¹°°ú ¾ö°ÝÇÑ ½ÂÀÎ ÇÁ·Î¼¼½ºµµ Å« Á¦¾àÀ̵Ǿú½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ Àü¸ÁÀ¸·Î´Â ºñ¿ë È¿À²ÀûÀÎ ¸ðµ¨ °³¹ß, ¹èÅ͸® ¼ö¸í Çâ»ó, ȯÀÚÀÇ Æí¾ÈÇÔ°ú ÄÄÇöóÀ̾𽺸¦ ±Ø´ëÈ­Çϱâ À§ÇÑ ¼ÒÇüÈ­ µîÀÌ ÀÖ½À´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶ó Á¤ºñ°¡ ÷´Ü Áø´Ü Åø¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ¼¼°èÀûÀÎ ½ÅÈï ½ÃÀå¿¡´Â °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. AI¿Í ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀ» Æ÷ÇÔÇÑ °øµ¿ ¿¬±¸´Â Áø´Ü ´É·Â°ú °³ÀÎÈ­µÈ ȯÀÚ °ü¸®¸¦ È®´ëÇϱâ À§ÇÑ ½ÇÁúÀûÀÎ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î ILR ½ÃÀåÀº Ä¿´Ù¶õ ¼ºÀå ±âȸ¸¦ °®°í ÀÖÀ¸¸ç, È®´ëµÇ´Â ½ÉÇ÷°ü Áø´ÜÀÇ Àü¸ÁÀ» ÃæºÐÈ÷ Ȱ¿ëÇϱâ À§Çؼ­´Â Àü·«Àû ÆÄÆ®³Ê½Ê°ú Çõ½Å Áß½ÉÀÇ Á¢±Ù ¹æ½ÄÀ¸·Î ±âÁ¸ °úÁ¦¸¦ ±Øº¹ÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 15¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 17¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 34¾ï ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 11.49%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°Í Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ë³â Àα¸ Áõ°¡¿Í ½ÉÀå Áúȯ ȯÀÚ Áõ°¡
    • ½ÉÀå ÁúȯÀÇ Ä¡·á¿¡ À־ÀÇ Ã¤¿ë Áõ°¡
    • °³¹ß µµ»ó±¹ÀÇ °Ç°­ °ü¸® ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀÌ½Ä °¡´ÉÇÑ ·çÇÁ ·¹ÄÚ´õ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • À̽ÄÇü ·çÇÁ ·¹ÄÚ´õÀÇ ±â¼úÀû Áøº¸
    • ÀÇ·á±â±âÀÇ ÀÓ»ó ¿¬±¸ÀÇ »õ·Î¿î ¿µ¿ª¿¡¼­ÀÇ »õ·Î¿î ÀÀ¿ëÀÇ ÃâÇö
  • ½ÃÀåÀÇ °úÁ¦
    • °¨¿° °¡´É¼º¿¡ µû¶ó µð¹ÙÀ̽º Á¦°Å°¡ ÇÊ¿ä

Porter's Five Forces : ÀÌ½Ä °¡´ÉÇÑ ·çÇÁ ·¹ÄÚ´õ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÌ½Ä °¡´ÉÇÑ ·çÇÁ ·¹ÄÚ´õ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀÌ½Ä °¡´ÉÇÑ ·çÇÁ ·¹ÄÚ´õ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ÀÌ·ç±â À§ÇÑ ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ³ëÀÎ Àα¸ Áõ°¡¿Í ½ÉÀå Áúȯ Áõ°¡
      • ½ÉÀ庴ÀÇ Ä¡·á¿¡ À־ÀÇ Ã¤¿ë Áõ°¡
      • °³¹ßµµ»ó±¹¿¡¼­ÀÇ ÇコÄɾî ÀÎÇÁ¶ó Á¤ºñ¸¦ ÇâÇÑ Á¤ºÎÀÇ ´ëóÀÇ °íÁ¶
    • ¾ïÁ¦¿äÀÎ
      • ÀÌ½Ä °¡´ÉÇÑ ·çÇÁ ·¹ÄÚ´õ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë
    • ±âȸ
      • À̽ÄÇü ·çÇÁ ·¹ÄÚ´õÀÇ ±â¼úÀû Áøº¸
      • ÀÇ·á±â±âÀÇ ÀÓ»ó Á¶»çÀÇ »õ·Î¿î ºÐ¾ß¿¡ À־ÀÇ »õ·Î¿î ÀÀ¿ë
    • °úÁ¦
      • °¨¿°ÀÇ °¡´É¼ºÀÌ ÀÖÀ¸¹Ç·Î, µð¹ÙÀ̽ºÀÇ Á¦°Å°¡ ÇÊ¿äÇÒ °æ¿ì°¡ ÀÖ½À´Ï´Ù
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå : Áúȯ ÀûÀÀÁõº°

  • ¾Æ¹Ð·ÎÀ̵åÁõ
  • ¼±Ãµ¼º ½ÉÀ庴
  • Æó»ö¼º ¼ö¸é½Ã ¹«È£Èí
  • ½ÅÀå À̽Ä
  • ³úÁ¹Áß

Á¦7Àå À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ½ÉÀå¼¾ÅÍ
  • º´¿ø

Á¦8Àå À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå : ¿ëµµº°

  • ½É¹æ¼¼µ¿
  • ºÎÁ¤¸Æ
  • ½ÉÀ强 ½Ç½Å

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • Angel Medical Systems, Inc.
  • BIOTRONIK SE & CO. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • Edwards LifeSciences
  • GE Healthcare
  • Koninklijke Philips NV
  • LifeWatch AG
  • Medtronic Plc.
  • Midmark Corporation
  • NIHON KOHDEN CORPORATION
  • Pulsion Medical Systems
  • Schiller AG
  • Sorin Group
  • Spacelabs Healthcare
  • St. Jude Medical Inc.
  • SunTech Medical, Inc
  • Vectorious Medical Technologies Ltd.
  • ZOLL Medical Corporation
BJH 24.12.19

The Implantable Loop Recorders Market was valued at USD 1.59 billion in 2023, expected to reach USD 1.76 billion in 2024, and is projected to grow at a CAGR of 11.49%, to USD 3.40 billion by 2030.

Implantable Loop Recorders (ILRs) are small, subcutaneously-placed devices used for continuous cardiac monitoring to detect arrhythmias over extended periods. They provide significant insights into transient symptoms that are difficult to capture with traditional ECGs, thereby offering a robust solution for patients with suspected but undiagnosed cardiac arrhythmic conditions. The principle necessity of ILRs lies in their long-term diagnostic capability which addresses limitations of short-term methods, making them essential in diagnosing cases of unexplained syncope, stroke attributable to arrhythmias, and cryptogenic stroke. Expanding applications include monitoring post-intervention atrial fibrillation and managing patients with elevated stroke risk. Major end-use segments comprise hospitals, cardiac care centers, and diagnostic clinics. Key growth factors for the ILR market include increasing prevalence of cardiovascular diseases, technological advancements enhancing device accuracy and data capture, and rising geriatric population with associated arrhythmic conditions. There's a burgeoning opportunity in integrating ILRs with advanced telemedicine solutions and AI-driven data analytics to facilitate real-time patient monitoring and predictive diagnostics. However, market growth faces challenges such as high costs of devices and procedures, limited awareness, and potential complications like infection or device-related issues. Regulatory hurdles and stringent approval processes also pose significant limitations. Innovation prospects include developing cost-effective models, enhancing battery life, and miniaturization to maximize patient comfort and compliance. There's potential in global emerging markets where healthcare infrastructure improvements can accommodate advanced diagnostic tools. Collaborative research involving AI and remote monitoring technologies offers substantial insight into expanding diagnostic capabilities and personalized patient care. Overall, the ILR market harbors significant opportunities for growth, necessitating strategic partnerships and innovation-centric approaches to overcome prevailing challenges in order to fully leverage the expanding cardiovascular diagnostic landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.59 billion
Estimated Year [2024] USD 1.76 billion
Forecast Year [2030] USD 3.40 billion
CAGR (%) 11.49%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Implantable Loop Recorders Market

The Implantable Loop Recorders Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population and rising cases of cardiac disorders
    • Increasing adoption in treatment of heart diseases
    • Rising government initiatives towards healthcare infrastructure in developing nations
  • Market Restraints
    • High cost associated with the implantable loop recorders
  • Market Opportunities
    • Technological advancements in implantable loop recorders
    • Emerging applications across novel fields of clinical research of medical devices
  • Market Challenges
    • Probability of infection might require device removal

Porter's Five Forces: A Strategic Tool for Navigating the Implantable Loop Recorders Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Implantable Loop Recorders Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Implantable Loop Recorders Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Implantable Loop Recorders Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Implantable Loop Recorders Market

A detailed market share analysis in the Implantable Loop Recorders Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Implantable Loop Recorders Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Implantable Loop Recorders Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Implantable Loop Recorders Market

A strategic analysis of the Implantable Loop Recorders Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Implantable Loop Recorders Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Angel Medical Systems, Inc., BIOTRONIK SE & CO., KG, Boston Scientific Corporation, Cardiac Science Corporation, Edwards LifeSciences, GE Healthcare, Koninklijke Philips N.V, LifeWatch AG, Medtronic Plc., Midmark Corporation, NIHON KOHDEN CORPORATION, Pulsion Medical Systems, Schiller AG, Sorin Group, Spacelabs Healthcare, St. Jude Medical Inc., SunTech Medical, Inc, Vectorious Medical Technologies Ltd., and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Implantable Loop Recorders Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Indication, market is studied across Amyloidosis, Congenital Heart Disease, Obstructive Sleep Apnea, Renal Transplant, and Stroke.
  • Based on End-user, market is studied across Cardiac Centers and Hospitals.
  • Based on Application, market is studied across Atrial Fibrillation, Cardiac Arrhythmia, and Cardiac Syncope.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and rising cases of cardiac disorders
      • 5.1.1.2. Increasing adoption in treatment of heart diseases
      • 5.1.1.3. Rising government initiatives towards healthcare infrastructure in developing nations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the implantable loop recorders
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in implantable loop recorders
      • 5.1.3.2. Emerging applications across novel fields of clinical research of medical devices
    • 5.1.4. Challenges
      • 5.1.4.1. Probability of infection might require device removal
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Implantable Loop Recorders Market, by Disease Indication

  • 6.1. Introduction
  • 6.2. Amyloidosis
  • 6.3. Congenital Heart Disease
  • 6.4. Obstructive Sleep Apnea
  • 6.5. Renal Transplant
  • 6.6. Stroke

7. Implantable Loop Recorders Market, by End-user

  • 7.1. Introduction
  • 7.2. Cardiac Centers
  • 7.3. Hospitals

8. Implantable Loop Recorders Market, by Application

  • 8.1. Introduction
  • 8.2. Atrial Fibrillation
  • 8.3. Cardiac Arrhythmia
  • 8.4. Cardiac Syncope

9. Americas Implantable Loop Recorders Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Implantable Loop Recorders Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Implantable Loop Recorders Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Angel Medical Systems, Inc.
  • 3. BIOTRONIK SE & CO., KG
  • 4. Boston Scientific Corporation
  • 5. Cardiac Science Corporation
  • 6. Edwards LifeSciences
  • 7. GE Healthcare
  • 8. Koninklijke Philips N.V
  • 9. LifeWatch AG
  • 10. Medtronic Plc.
  • 11. Midmark Corporation
  • 12. NIHON KOHDEN CORPORATION
  • 13. Pulsion Medical Systems
  • 14. Schiller AG
  • 15. Sorin Group
  • 16. Spacelabs Healthcare
  • 17. St. Jude Medical Inc.
  • 18. SunTech Medical, Inc
  • 19. Vectorious Medical Technologies Ltd.
  • 20. ZOLL Medical Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦